A series of compounds with known inhibitory activity for C-C chemokine receptor type 3 (CCR3) was considered in order to build a predictive model useful in further development of novel CCR3 inhibitors. Model was built using topological descriptors (Cluj indices included) and multiple linear regression. Principal component analysis was applied in order to enhance the model. Errors were taken into consideration and discussed. Finally, vertex invariants based on thermal conductivity layer matrix proved to be a valuable tool in bioactivity prediction of CCR3 inhibitors.
INTRODUCTION
C-C chemokine receptor type 3 (CCR 3 ), recently designated cluster for differentiating CD193, is highly expressed in eosinophils [1] . Its function is the accumulation and activation of eosinophils at the site of an immune stimulus (allergy, parasitic infection, etc.). A chemokine inhibitor will prohibit this proinflammatory effect. A series of broad spectrum chemokine inhibitors (BSCI) were designed. Remarkably, peptide 3'', a dodecapeptide section of chemokine (C-C-motif) ligand 2 (CCL2) was proven to be a functional inhibitor of many chemokines [2] . The crucial peptide sequence responsible for its effect was identified as the tripeptide AcNH-Trp-Val-Gln-OH. Peptide mimetics were fashioned mainly a range of 3-acylaminoglutarimides, with low nM BSCI potencies [3] . A particular interest exists for cyclic peptide NR58-3.14. CCR 3 was shown to inhibit HIV replication [4] . In this respect, there is an entry coreceptor for HIV-1. This gene receptor and other chemokine receptors genes form a cluster on chromosomal region 3p21 [5] . A number of small molecules with inhibitor effect on CCR 3 (expressed as IC50, nM) were studied. In this work, a prediction model based on computed data regarding molecules that act as inhibitors of CCR 3 was carried out, in order to be used as a tool for further development of these compounds.
RESULTS AND DISCUSSION
A set of 41 compounds with inhibitory effect on CCR 3 was selected from PubChem (Table 1) , on which topological indices [6] , encoding fragmental topo-chemical information [7] [8] [9] , were computed by means of layer matrices [11] [12] [13] [14] . The fragmental properties were chosen the mass M and thermal conductivity Tc (Table 2) .
In order to select the descriptors for model building, a monovariate correlation between each descriptor and the dependent variable (IC 50 [13] was computed using all mass and thermal conductivity descriptors. Dependent variable was chosen IC 50 . Pearson correlation (r) retrieved was r=0.632, with r 2 =0.399, Spearman rank correlation (p)=0.673, cross validated squared (q 2 ) =0.399, y=0.399x+12.11. Based on PCA, principal components (PC) 1-8 for variables listed in Table 2 were computed. Results are shown in Table 3 .
In order to build a model using descriptors listed in Table 1 and PC showed in Table 3 , a multi-variate correlation between target variable and descriptors was performed. Conclusive results are shown in Table 4 .
A model using correlation (entry 5) (Table 4) was built with IC 50 (nM) as dependent variable. This solution was chosen mainly because of its correlation with the target variable (r 2 =0.999) and the reduced number of descriptors (4) . The plot of correlation between predicted IC 50 p and IC 50 o experimentally determined (observed) is shown in Fig. 1 . In Table 5 
4.000 4.049 The results obtained by using simple descriptors alone (without PC values) are rather modest. Best r 2 value described in literature is 0.960 on a series of 4-benzylpiperidinealkylurease CCR3 antagonist with a model obtained by using CoMFA methodology [10] . However, the cited study used a vast set of descriptors. The approach by local vertex invariants based on thermal conductivity descriptors, within Cluj descriptors, has the advantage of using a small number of descriptors which encode both topological and physico-chemical properties of a ligand. Correlation obtained supports the supposition that thermal conductivity and topological information plays a distinct role in bioactivity of these compounds. Furthermore, by using PCA, a significant increase in predictive performance of the model is obtained. Certainly, this model is not the best CCR3-interaction estimator but regardless of collinearity and multi-collinearity introduced by using PCA, the model is a good predictor of bioactivity of the studied compounds, as demonstrated below. In Table 6 , standard errors are listed. Standard error is a measure of divergence of estimator value from the expected value.
Average standard deviation computed was 19.665. Percentage error and percent difference error, calculated for observed and predicted values are listed in Table 6 .
Multicollinearity has no impact on the regression model and association statistics such as r 2 , F ratio and p values. It also should not generally have an impact on prediction made using the overall model. Tolerance and VIF are two main tests in detecting multicollinearity. Results are represented in Tables 7 and 8 . Fig. 2 shows data dimensionality, although r 2 =0.999 variations are observed. For two variables 1-100% interval is violated. In this case there is a lack of accuracy and precision. Random errors evaluation is represented in Fig. 3 ; there are no randomization errors. However, there is a violation in data dimensionality for variables 27 and 37. 
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Randomized errors were also computed. In this respect, 5 models using same descriptors, same methods of model generation and evaluation were used. Models were compared using a stacked column plot.
CONCLUSIONS
Bioactivity prediction using local vertex invariants based on thermal conductivity layer matrix is a good methodology in predicting activity of C-C chemokine receptors type 3 inhibitors.
PCA is a valuable tool in optimizing a regression model. Accuracy and precision errors affecting data dimensionality were detected in the model. Such errors may occur even at high values of r 2 . Random errors were uncommon in this type of model and were not observed.
